tweenvest

Taho Pharmaceuticals Ltd. (TWSE: 6467)

Health Care · Pharmaceuticals · TW

NT$224.50

-2.81% today · +30.9% 1Y

Public summary
A free snapshot of Taho Pharmaceuticals Ltd., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Taho Pharmaceuticals Ltd. (TWSE: 6467) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $357.09M.

Over the last twelve months the share price has gained 30.9%, trading between 100.50 and 302.00.

Tweenvest scores Taho Pharmaceuticals Ltd. across four factors: quality 36/100, value 92/100. Its strongest factor is value.

6467 price history

Nov 21, 2025 · 171.50Weekly closes 104.00 – 291.50Nov 18, 2026 · 224.50

Key figures

Market cap
$357.09M
Revenue (TTM)
$196.35K
P/E
-46.94
EPS
-4.59
Dividend yield
—
Beta (5Y)
-0.74
52-week high
NT$302.00
52-week low
NT$100.50
Avg volume (3M)
—
Shares outstanding
52.41M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Boiron SAENXTPA: BOI$363.98M€19.100.00%
Unichem Laboratories LimitedBSE: 506690$362.79MRs485.85-2.45%
Anhui Fengyuan Pharmaceutical Co., Ltd.SZSE: 000153$358.87MCN¥5.15-1.15%
Abbott Laboratories (Pakistan) LimitedKASE: ABOT$357.24MPKRs1,009.02+0.35%
Egyptian International Pharmaceutical Industries CompanyCASE: PHAR$354.36MEGP112.21-0.24%
Solara Active Pharma Sciences LimitedNSEI: SOLARA$352.90MRs689.65+1.98%
Vireo Growth Inc.CNSX: VREO$346.92MCA$9.45-2.07%
Zhejiang Xinguang Pharmaceutical Co., Ltd.SZSE: 300519$346.36MCN¥14.45-3.41%

Browse every Pharmaceuticals company →